If it works well for the customers, we will sell more than enough.  This is not like a huge pharma announcing good phase 3 results, it's more like a micro-cap biotech announcing FDA approval. 

One "advantage " of our size, is we don't have to sell a billion dollars worth of these devices to make a huge change in our financials!  And perhaps even our share price...